company
ID Biomedical Corporation of Quebec
GSK Acquires Influenza Vaccine Manufacturer ID Biomedical Corporation
http://www.medicalnewstoday.com/releases/34803.php
GlaxoSmithKline plc (NYSE:GSK) announced the completion of the acquisition of ID Biomedical. This follows regulatory clearances of the transaction and adoption of the acquisition agreement by ID Biomedical's shareholders (which occurred on the 16th of November). ID Biomedical becomes a wholly-owned subsidiary of GSK. ...
YL